This brand name is authorized in Austria, Australia, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Singapore, Turkey, South Africa
The drug KONAKION contains one active pharmaceutical ingredient (API):
|
1
Phytomenadione
UNII A034SE7857 - PHYTONADIONE
|
|
The presence of vitamin K (i.e. vitamin K or substances with vitamin K activity) is essential for the formation within the body of prothrombin, factor VII, factor IX and factor X. Lack of vitamin K leads to an increased tendency to haemorrhage. When an antidote to an anticoagulant is necessary it is essential to use vitamin K1 itself, as vitamin K analogues are much less effective. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| KONAKION MM PAEDIATRIC Solution (ampoules) | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| KONAKION MM Solution (ampoules) | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B02BA01 | Phytomenadione | B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BA Vitamin K |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10213M |
| Country: EE | Ravimiamet | Identifier(s): 1799242, 1803248, 1803350, 1803642, 1820652, 1870062 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 008776078IP, 21610, 27262, 8776078 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 404939 |
| Country: HK | Department of Health Drug Office | Identifier(s): 30412, 38859 |
| Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-364029156 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 30457, 30493 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 3032, 3677 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1090601, 1090602 |
| Country: MT | Medicines Authority | Identifier(s): AA1411/01901, AA1456/00101, AA565/08802, AA565/08803, AA565/78201, AA729/00905 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 13577719, 14145804 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 48232 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 3780, 3781 |
| Country: SG | Health Sciences Authority | Identifier(s): 08533P, 09412P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8680979254035, 8680979254042 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 29/22/0492 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
